Dutton adds new medicines to Pharmaceutical Benefits Scheme

SUFFERERS of cystic fibrosis and a rare disease that attacks organ function will be able to access cheaper treatments from December.

Health Minister Peter Dutton today announced two new medicines for the diseases would be listed on the Pharmaceutical Benefits Scheme.

The medicines, Kalydeco, for cystic fibrosis and Soliris, or atypical haemolytic uraemic syndrome, will be listed from December 1.

Mr Dutton said listing the Kalydeco medicine would help more than 250 Australians affected by cystic fibrosis, saving about $300,000 a year for each patient.

He also said listing the Soliris medicine, for the ultra-rare aHUS condition, would help sufferers and their families meet the $500,000 annual cost of that medicine.

Listing both medicines on the PBS will cost the government about $238 million over the next four years, the drug manufacturers will have to meet some conditions prior to the listing.

Topics:  cystic fibrosis health pbs peter dutton pharmaceutical benefits scheme

Stay Connected

Update your news preferences and get the latest news delivered to your inbox.

Next generation of yogis learn in the Lockyer

TUNING IN: Sarah Weber runs her kids yoga class once a week, each term from her Cura Life Studio in Gatton.

Yoga teacher Sarah Weber shares the benefits of starting yoga early.

All's Wells for Madi after third national silver medal

RISING STAR: Lockyer District Athletic Club's Madison Wells celebrates her latest silver medal success with mum Sharyn and dad Lee in Melbourne.

Madison Wells won silver at the Australian Multi-events titles.

Bid on hot cross buns to help raise funds

GOING HOT: The Old Fernvale Bakery aim to raise $40,000 for the Lady Cilento Childrens Hospital by donating $1 from every pack of hot cross buns sold. Pictured here are Lyn and Bill Rose with the latest hot cross bun creation, cranberry, pistachio and white chocolate.

Help the Old Fernvale bakery get over the line.

Local Partners